Higher frequencies of mutations in neurofibromatosis (NF1), ataxia telangiectasia and Rad3 related (ATR), and breast cancer (BRCA1) genes have been reported in EGFR-mutant SCCs compared to EGFR-mutant adenocarcinomas [68]. This evidence concerns the gene EGFR and adenocarcinoma.